Results 21 to 30 of about 21,359 (272)

Esophagogastric junction outflow obstruction

Neurogastroenterology & Motility, 2021
AbstractIn the Chicago Classification version 4.0 (CCv4), esophagogastric junction outflow obstruction (EGJOO) is manometrically defined as an elevated median integrated relaxation pressure (IRP) and elevated intrabolus pressure (IBP) during supine wet swallows, and persistently elevated median IRP in the upright position.
Albert J. Bredenoord, Arash Babaei, Dustin Carlson, Taher Omari, Jun Akiyama, Rena Yadlapati, John E. Pandolfino, Joel Richter, Ronnie Fass   +8 more
openaire   +3 more sources

A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration

Surgical Case Reports, 2021
Background The abscopal effect is a rare phenomenon in which local irradiation causes tumor regression outside the irradiated area. There have been no reports of abscopal effect in patients with gastrointestinal melanoma with metastasis.
Takahisa Yamaguchi, Sachio Fushida, Jun Kinoshita, Hiroto Saito, Mari Shimada, Shiro Terai, Hideki Moriyama, Koichi Okamoto, Keishi Nakamura, Itasu Ninomiya, Noriyuki Inaki   +10 more
doaj   +1 more source

Recurrence following anastomotic leakage after surgery for carcinoma of the distal esophagus and gastroesophageal junction. a systematic review [PDF]

, 2019
BACKGROUND: Esophageal cancer is the ninth most common cancer. The only potentially curative treatment is surgical resection, which unfortunately is still associated with major complications, the most important being anastomotic leakage, currently with ...
Antolino, Laura, Aurello, Paolo, Berardi, Giammauro, Cinquepalmi, Matteo, D'Angelo, Francesco, GIOVANNI RAMACCIATO, And, Moschetta, Giovanni, Nigri, Giuseppe, Valabrega, Stefano   +8 more
core   +1 more source

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma [PDF]

, 2013
This study aimed at determining the recommended dose of the mammalian target of rapamycin inhibitor everolimus in combination with mitomycin C (MMC) in patients with previously treated metastatic esophagogastric cancer.
Atmaca, Akin, Batran, Salah-Eddin al-, Jäger, Elke, Pauligk, Claudia, Pustowka, Anette, Werner, Dominique   +5 more
core   +1 more source

F-18-FDG and C-11-choline positron emission tomography in human esophago-gastric cancer : prediction of response to therapy [PDF]

, 2010
Peer reviewedPublisher ...
Hammonds, Solveig, McAteer, Dympna, Nicolson, Marianne, Park, Kenneth, Schweiger, Lutz, Sheehan, Margaret, Smith, Timothy, Suttie, Stuart, Welch, Andrew   +8 more
core   +1 more source

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the International BEACON Consortium [PDF]

, 2010
BackgroundPrevious studies that showed an association between smoking and adenocarcinomas of the esophagus and esophagogastric junction were limited in their ability to assess differences by tumor site, sex, dose–response, and duration of cigarette ...
Abnet, C.C., Bernstein, L., Brown, L.M., Casson, A.G., Chow, W.H., Cook, M.B., Corley, D.A., Freedman, N.D., Gammon, M.D., Giffen, C., Kamangar, F., Linda, Sharpe, Murray, Liam, Nyren, O., Pandeya, N., Risch, H.A., Vaughan, T.L., Ward, M.H., Webb, P.M., Whiteman, D.C., Wu, P.M., Ye, W.   +21 more
core   +1 more source

Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations [PDF]

, 2010
Background: Gastroesophageal reflux disease (GERD) results primarily from the loss of an effective antireflux barrier, which forms a mechanical barrier against the retrograde movement of gastric content.
Reginald C. W. Bell, Guy-Bernard Cadière   +1 more
core   +1 more source

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

BMC Cancer, 2019
Background The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients.
Xiaowen Liu, Jiejie Jin, Hong Cai, Hua Huang, Guangfa Zhao, Ye Zhou, Jianghong Wu, Chunyan Du, Ziwen Long, Yantian Fang, Mingze Ma, Guichao Li, Menglong Zhou, Jiliang Yin, Xiaodong Zhu, Ji zhu, Weiqi Sheng, Dan Huang, Hui Zhu, Zhaozhen Zhang, Qi Lu, Li Xie, Zhen Zhang, Yanong Wang   +23 more
doaj   +1 more source

Evaluation of the incidence of splenic hilar lymph node metastasis in patients operated on for esophagogastric junction cancer

Nowotwory, 2023
INTRODUCTION: The purpose of this study is to evaluate the effect of esophagogastric junction cancer (EGJC) staging on the risk of splenic hilar lymph node involvement. MATERIAL AND METHODS: 312 patients with EGJC after R0 surgery were analyzed; 118 (38%)
Tomasz Olesiński, Marek Szpakowski, Wojciech Każmierczak, Urszula Sulkowska, Andrzej Rutkowski   +4 more
doaj   +1 more source

Diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution MRI: a comparison with conventional MRI at 3 tesla

Cancer Imaging, 2019
Background To investigate and compare the diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution magnetic resonance imaging (HR MRI), as compared with conventional MRI at 3 Tesla.
Yuan Yuan, Luguang Chen, Shengnan Ren, Zhen Wang, Yukun Chen, Aiguo Jin, Shuai Li, Xu Fang, Tiegong Wang, Yun Bian, Qingsong Yang, Chenguang Bai, Qiang Hao, Jianping Lu   +13 more
doaj   +1 more source